Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.

Author: BakerWilliam L, BergKarina M, ColemanCraig I, HernandezAdrian V, MartinezBrandon K, RossJoseph S, SobierajDiana M, SteffensDavid C

Paper Details 
Original Abstract of the Article :
OBJECTIVES: To assess adverse effects of pharmacologic antidepressants for treatment of major depressive disorder (MDD) in adults 65 years of age or older. DESIGN: Systematic review and meta-analysis. SETTING: Specialist or generalist outpatient setting, rehabilitation facility, and nursing facili...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/jgs.15966

データ提供:米国国立医学図書館(NLM)

The Impact of Antidepressants on Older Adults

This research delves into a crucial topic in geriatric medicine, exploring the adverse effects of pharmacologic treatments for depression in older adults (aged 65 and above). The study, a systematic review and meta-analysis, employed a robust methodology to assess the effectiveness and safety of various antidepressants, including SSRIs, SNRIs, and others, compared to placebo or non-pharmacologic therapies. Their findings indicate that SNRIs, but not SSRIs, were associated with a statistically significant increase in overall adverse events compared to placebo during the acute treatment phase. Both SSRIs and SNRIs resulted in a higher rate of study withdrawals due to adverse events. Furthermore, duloxetine, a specific SNRI, was linked to an increased risk of falls during the acute and continuation treatment phases.

Implications for Prescribing Antidepressants

The study highlights the need for careful consideration when prescribing antidepressants to older adults, particularly SNRIs. These findings suggest that a tailored approach, considering individual patient characteristics and risk factors, is essential for optimizing treatment outcomes and mitigating potential side effects. These results are particularly significant given the growing population of older adults and the increasing prevalence of depression in this demographic.

Older Adults: Navigating the Oasis of Antidepressants

Think of it like this, my friend: Imagine a vast desert of depression, with older adults needing to find a path to well-being. Antidepressants are like oases, offering respite and potential healing, but just like a desert, some oases are safer than others. This research helps us better understand the risks and benefits of these different oases, allowing us to guide patients towards the best path for their individual needs.

Dr.Camel's Conclusion

This study sheds light on the potential risks associated with certain antidepressants in older adults. The findings underscore the importance of careful medication selection and close monitoring to minimize adverse events and maximize therapeutic benefits. While antidepressants offer a crucial lifeline for many, it is essential to approach their use with a balanced perspective, considering both their potential benefits and their potential risks.
Date :
  1. Date Completed 2020-05-25
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

31140587

DOI: Digital Object Identifier

10.1111/jgs.15966

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.